Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, April 13, 2018
Eisai Enters Into Joint Research Agreement With the Broad Institute, Colorado State University, and University of Chicago
Monday, April 2, 2018
Eisai Submits Supplemental New Drug Application to U.S. FDA
Wednesday, March 28, 2018
Eisai and Nichi-Iko Pharmaceutical Enter Into Strategic Alliance Agreement
Friday, March 23, 2018
AbbVie and Eisai Obtain Additional Approval for New Indication of Fully Human Anti-TNF-alpha Monoclonal
Eisai: Anticancer Agent LENVIMA Approved for Additional Indication of Unresectable Hepatocellular Carcinoma (HCC) in Japan
Wednesday, March 14, 2018
Eisai Launches Gastrointestinal Prokinetic Agent Cidine (Cinitapride Hydrogen Tartrate) in China
Thursday, March 8, 2018
Eisai and Merck & Co. Enter Global Strategic Oncology Collaboration for LENVIMA
Eisai and Purdue Pharma Announce Positive Topline Results From Key Clinical Studies of Lemborexant
Tuesday, February 27, 2018
Eisai: Launch of "Dementia Support" Insurance to Provide for Dementia in Japan
Wednesday, February 21, 2018
Eisai Certified in 2018 as Outstanding Health and Productivity Management Organization (White 500)

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: